JP‐1302: a new tool to shed light on the roles of α2C‐adrenoceptors in brain

Article date: February 2007

By: M D Tricklebank in Volume 150, Issue 4, pages 381-382

The discovery of JP‐1302 as a selective, high affinity antagonist at the α2C‐adrenoceptor will enable researchers to probe the functional role and address the therapeutic utility of this potentially highly important adrenoceptor subtype.

British Journal of Pharmacology (2007) 150, 381–382. doi:10.1038/sj.bjp.0707007

DOI: 10.1038/sj.bjp.0707007

View this article